Skip to main content

Moderna posts wider-than-expected loss, reins in full-year outlook

COVID vaccine maker unwinds pandemic-era manufacturing capacity as it aims to break even in 2026
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.